Frequency and characterization of p53 mutations in clinically localized prostate cancer

Author： Hall M.C.   Navone N.M.   Troncoso P.   Pollack A.   Zagars G.K.   von Eschenbach A.C.   Conti C.J.   Chung L.W.K.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.45, Iss.3, 1995-03, pp. : 470-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53

By Stricker H.J.   Jay J.K.   Linden M.D.   Tamboli P.   Amin M.B.  

Urology, Vol. 47, Iss. 3, 1996-03 ,pp. : 366-369

Elsevier

Access to resources Recommend Favorite

Review of staging modalities in clinically localized prostate cancer

By Perrotti M.   Pantuck A.   Rabbani F.   Israeli R.S.   Weiss R.E.  

Urology, Vol. 54, Iss. 2, 1999-08 ,pp. : 208-214

Elsevier

Access to resources Recommend Favorite

Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer

By Dillioglugil O.   Leibman B.D.   Kattan M.W.   Seale-Hawkins C.   Wheeler T.M.   Scardino P.T.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 93-99

Elsevier

Access to resources Recommend Favorite

Urinary incontinence following external-beam radiotherapy for clinically localized prostate cancer

By Lee W.R.   Schultheiss T.E.   Hanlon A.L.   Hanks G.E.  

Urology, Vol. 48, Iss. 1, 1996-07 ,pp. : 95-99

Elsevier

Access to resources Recommend Favorite

The Role of the Complexed-to-Total Prostate-Specific Antigen Ratio in Predicting the Final Pathological Stage of Clinically Localized Prostate Cancer

By Martnez M.   Navarro S.   Medina P.   Villavicencio H.   Rioja L.   Solsona E.   Estelles A.   Aznar J.   Jimenez-Cruz J.F.   Espana F.  

European Urology, Vol. 43, Iss. 6, 2003-06 ,pp. : 609-614

Elsevier

Access to resources Recommend Favorite